Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares, ADSs

22nd Apr 2014 06:33

LONDON (Alliance News) - GlaxoSmithKline PLC Thursday said a group of executives including Chief Executive Officer Andrew Witty acquired shares and American Depositary Shares under the company performance share plan at a price of 1581.50 pence per share and USD52.55 per ADS Wednesday.

Details are as follows.

Director/PDMR

Ordinary Shares

ADSs

Sir Andrew Witty

19,564.837

 

Dr M M Slaoui

 

5,637.905

Mr S Dingemans

8,217.586

 

Mr S M Bicknell

1,325.959

 

Mr R G Connor

2,687.452

 

Mrs D P Connelly

 

2,344.551

Mr J Ford

 

303.243

Mr S A Hussain

6,666.166

 

Mr W C Louv

 

1,653.860

Mr D S Redfern

2,829.821

 

Ms C Thomas

3,905.590

 

Mr P C Thomson

1,905.093

 

Mr D E Troy

 

3,350.705

Dr P J T Vallance

8,136.668

 

Ms E Walmsley

4,729.965

 

Mrs V A Whyte

541.530

 


The company also said, a group of executives bought ADSs at USD52.0208 each April 10, which are detailed below.

Director/PDMR

 

 

 

Number of ADSs

 

Connected Person

 

Number of ADSs

 

Dr M M Slaoui

 

 

1,788.686

 

Dr K Slaoui

 

20.762

 

Mrs D P Connelly

 

895.847

 

-

 

-

 

Mr J Ford

 

34.235

 

-

 

-

 

Mr W C Louv

 

301.078

 

-

 

-

 

Mr D E Troy

 

 

825.851



The company further said Deidre Connelly and Bill Louv, both divisional executives acquired ADSs at USD53.007 each details are outlined below.

Mrs D P Connelly

Acquisition of 45.263 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 33.354 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr W C Louv

Acquisition of 33.140 ADSs under the personal contribution element of the Plan.


Glaxo shares closed at 1,550.12 pence dowb 13.38p Thursday.

By Arvind Bhunjun; [email protected]; @ArvindBhunjun

Copyright © 2014 Alliance News Limited. All Rights Reserved.


Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,735.60
Change16.85